Last reviewed · How we verify

Pentosan Polysulfate Sodium Fixed Dose

Paradigm Biopharmaceuticals USA (INC) · Phase 2 active Small molecule

Pentosan Polysulfate Sodium Fixed Dose is a Small molecule drug developed by Paradigm Biopharmaceuticals USA (INC). It is currently in Phase 2 development. Also known as: Fixed Dose.

At a glance

Generic namePentosan Polysulfate Sodium Fixed Dose
Also known asFixed Dose
SponsorParadigm Biopharmaceuticals USA (INC)
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Pentosan Polysulfate Sodium Fixed Dose

What is Pentosan Polysulfate Sodium Fixed Dose?

Pentosan Polysulfate Sodium Fixed Dose is a Small molecule drug developed by Paradigm Biopharmaceuticals USA (INC).

Who makes Pentosan Polysulfate Sodium Fixed Dose?

Pentosan Polysulfate Sodium Fixed Dose is developed by Paradigm Biopharmaceuticals USA (INC) (see full Paradigm Biopharmaceuticals USA (INC) pipeline at /company/paradigm-biopharmaceuticals-usa-inc).

Is Pentosan Polysulfate Sodium Fixed Dose also known as anything else?

Pentosan Polysulfate Sodium Fixed Dose is also known as Fixed Dose.

What development phase is Pentosan Polysulfate Sodium Fixed Dose in?

Pentosan Polysulfate Sodium Fixed Dose is in Phase 2.

Related